Kensey Nash Corporation 735 Pennsylvania Drive Exton,
PA 19341 United States - Map Phone: 484-713-2100 Fax: 484-713-2900 Website: http://www.kenseynash.com
Kensey Nash Corporation, a medical device company, engages in the field of regenerative medicine products and technologies to help repair damaged or diseased tissues. The company involves in designing, developing, manufacturing, and processing proprietary medical devices, including resorbable biomaterial products, such as synthetic polymers and collagen. It provides various orthopaedic market products comprising soft tissue and bone fixation products for the fixation and repair of musculoskeletal tissues; and bone void fillers and scaffolds. The company also offers cardiovascular market products that include original Angio-Seal device, a vascular closure device; general surgery market products, which consist of ECM product, a porcine dermis surgical mesh used for abdominal wall reconstruction, breast reconstruction, and select head and neck plastic surgery repair, as well as manufactures resorbable carriers for the breast biopsy markers. In addition, it provides dental barrier membranes and resorbable materials that are used in ophthalmology applications. The company sells its products through strategic partners in various medical markets, including cardiology, orthopaedic, sports medicine, spinal cranio-maxillofacial, trauma, and general surgery. Kensey Nash Corporation was founded in 1984 and is headquartered in Exton, Pennsylvania. Key Statistics
| |
| Kensey Nash Corporation’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Low Concern), Board (Low Concern), Compensation (Low Concern), Shareholder Rights (High Concern). | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. Joseph W. Kaufmann ,
60 Chief Exec. Officer, Pres, Sec. and Director | 350.00K | 2.47M | Mr. Michael Celano CPA,
53 Chief Financial Officer | 265.00K | 0.00 | Mr. Douglas G. Evans P.E,
48 Chief Operating Officer, Assistant Sec. and Director | 317.00K | 1.93M | Mr. James T. Rauth P.E,
48 VP of Operations | 211.00K | 26.00K | Mr. Todd M. DeWitt Ph.D.,
58 VP of Biomaterials | 212.00K | 9.00K |
|
| | Amounts are as of Dec 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|